Fox et al. demonstrated that reintroducing AMPKα2 suppressed the growth of MCF-7 breast cancer cells [55]; whereas, in a different study overexpressing a constitutively active form of AMPK reduced cell death induced by low glucose [56]. Here, PRKAA2 is linked to breast carcinoma.